Hardman & Co Q&A on Fidelity European Trust
Hardman & Co Video | Analyst interview
Q&A on Fidelity European Trust (FEV) |
Fidelity European Trust is the topic of conversation when Hardman & Co Investment Companies Analyst Riccardo Bindi joins DirectorsTalk Interviews.
Riccardo gives an overview of his note , explains why he thinks Fidelity European Trust investment philosophy and long-term track record are worth revisiting, touches on some macro issues and shares his thoughts on fees and turnover.
Listen to the interview here : https://youtu.be/FZYn5hOhHtA
To read the transcript of this interview, click here .
If you are interested in meeting the company, you can register your interest here .
|
To contact us:
Hardman & Co London EC2R 8AE www.hardmanandco.com Follow us on Twitter @HardmanandCo |
Contact: Riccardo Bindi
|
|
Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.
About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.
Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.
Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 hours ago Alphawave IP Group
- 3 hours ago WH Smith
- 3 hours ago Staffline Group
- 3 hours ago Manchester & London Investment Trust
- 4 hours ago Associated British Foods